中文 | English
Return
Total: 58 , 1/6
Show Home Prev Next End page: GO
Author:(ZHANG YUANFANG)

1.Clinical study on 45 cases with endogenous caesarean scar pregnancy

Xiaoqiao LI ; Yuanfang ZHANG

Chinese Journal of Primary Medicine and Pharmacy 2015;(21):3283-3285

2.Progressive researchs of survivin in urological cancer

Xiang YAN ; Qiang DING ; Yuanfang ZHANG

Journal of Medical Postgraduates 2003;0(08):-

3.Interferon gamma enhances the cytotoxicity of 5′-deoxy-5-fluorouridine and 5-fluorouracil against human bladder cancer cells

Gang LI ; Yuanfang ZHANG ; Qiang DING

Chinese Journal of Urology 2001;0(07):-

4.Single intravesical instillation of epirubicin for primary superficial bladder carcinoma:long-term results

Benchun LIU ; Yuanfang ZHANG ; Zhong WANG

Chinese Journal of Urology 2001;0(06):-

5.Immune hyporesponsiveness induced by immature dendritic cells prolonged rat kidney allograft survival

Xiang WANG ; Hong ZHAO ; Yuanfang ZHANG

Chinese Journal of Organ Transplantation 1996;0(04):-

6.A study of polymorphism of STR D13S325 locus in Chinese Han poplulation in Wuhan

Guohua CHEN ; Li CHEN ; Yuanfang ZHANG

Chinese Journal of Forensic Medicine 1986;0(02):-

7.SELDI-TOF-MS ProteinChip technology for screening of urine markers of bladder carcinoma

Denglong WU ; Yuanfang ZHANG ; Ming GUAN

Chinese Journal of Urology 2001;0(07):-

8.INFLUENCE OF TRACE ELEMENTS As, Se, Te, Re, Ir ON CELL PROLIFERATION OF TETRAHYMENA PYRIFORMIS

Renhuan TANG ; Xiaoming LI ; Qingxi ZHANG ; Yuanfang LIU ;

Acta Nutrimenta Sinica 1956;0(03):-

9.The diagnosis and treatment of urachal carcinoma(Report of three cases and literature review)

Benchun LIU ; Yuanfang ZHANG ; Zhong WANG ; Al ET

China Oncology 1998;0(04):-

10.Efficacy and safety of a bFGF inhibitor,tadenan in the treatment of benign prostatic hyperplasia:a multicenter trial in China

Jie JIN ; Hua MEI ; Yuanfang ZHANG ; Al ET

Chinese Journal of Urology 2000;0(01):-

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 58 , 1/6 Show Home Prev Next End page: GO